Azeezat M Lawal - FDA Investigator Report

Overview Statistics

8
Total Inspections
6
Total 483s Issued
0
Warning Letters Issued

Inspection Details

Longest Inspection: 15 days
Shortest Inspection: 3 days
Average Length: 6.9 days

Discover the bigger picture. This is just the tip of the iceberg.

Gain access to comprehensive analysis, detailed reports, AI assistant, and much more.

Schedule a Demo

Azeezat M Lawal's Recent Inspections

DateCompanyCityCountryFEI Number483
2025-02-27C-Care, LLCLinthicum HeightsUnited States3003071856
2024-12-13Genus Lifesciences Inc.AllentownUnited States3014677161
2024-08-29Sharp Clinical Services, LLCBethlehemUnited States3003673570
2024-06-12Hikma Pharmaceuticals USA Inc.Cherry HillUnited States2220525
2024-04-09Eisai, Inc.BaltimoreUnited States1000158705
2024-02-15ChemPacific CorporationBaltimoreUnited States3003299802
2024-01-18United States Department of Health & Human ServicesPerry PointUnited States1111596
2023-12-15Granules Pharmaceuticals Inc.ChantillyUnited States3011585184

Sign Up to get the complete report.

Download 483s and EIRs for Azeezat M Lawal

Azeezat M Lawal - Co-Inspectors

NameInspectionsLast Inspection
Yaharn Su32025
Johnny D Nwankwo32024
Nelson N Ayangho22024
Tekalign Wondimu22024
Stephenie M Ortiz12025
Christian F Gomez Lugo12024
Catherine O Lamptey12024
Paige R Mccoy12024
Evan Tong12024
Yoriann M Cabrera Bartolomei12024
Pamela N Agaba12024
Pushpa S Jayasekara12024
Victoria Spivak12024
Mindy M Chou12024
Christina K Theodorou12024
David A Oluwo12024

Azeezat M Lawal's Active Locations

  • United States

Azeezat M Lawal's Year-wise Inspection Count

  • 2023:1 inspections
  • 2024:6 inspections
  • 2025:1 inspections
Last Updated: 2025-05-14 06:11:22